Evidence map›Paper›PMID 37876851›Full record

ArticleExploratory research in clinical and social pharmacy2023

Patient reported goals for medications for opioid use disorder: A theory of proximal goal attainment.

Kenneth C Hohmeier, Alina Cernasev, Christina Leibold, Todd M Moore, Erica Schlesinger, Ileana Arce, Wesley Geminn, Marie Chisholm-Burns, Gerald Cochran

Open access · goldAbstract read
In one paragraph

Article in Exploratory research in clinical and social pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kenneth C HohmeierUniversity of Tennessee Health Science Center, College of Pharmacy, Department of Clinical Pharmacy and Translational Science, Nashville, TN 37211, USA.
Alina CernasevUniversity of Tennessee Health Science Center, College of Pharmacy, Department of Clinical Pharmacy and Translational Science, Nashville, TN 37211, USA.
Christina LeiboldUniversity of Tennessee Health Science Center, College of Pharmacy, Department of Clinical Pharmacy and Translational Science, Nashville, TN 37211, USA.
Todd M MooreUniversity of Tennessee, Department of Psychology, Knoxville, TN 37996, USA.
Erica SchlesingerTennessee Department of Mental Health & Substance Abuse Services, Nashville, TN 37243, USA.
Ileana ArceTennessee Department of Mental Health & Substance Abuse Services, Nashville, TN 37243, USA.
Wesley GeminnTennessee Department of Mental Health & Substance Abuse Services, Nashville, TN 37243, USA.
Marie Chisholm-BurnsOregon Health & Science University, Office of the Provost, Portland, OR 97239, USA.
Gerald CochranUniversity of Utah, Division of Epidemiology, Salt Lake City, UT 84112, USA.
Tennessee Department of Mental Health and Substance Abuse Services · USUniversity of Tennessee Health Science Center · USOregon Health & Science University · USUniversity of Tennessee at Knoxville · USUniversity of Utah · US

Funding

Greater Intermountain Node (CTN-0151)UG1DA049444 · NIDA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Gerald T. Cochran, Gerald T. Cochran · 2019 to 2026
$16.8M
NIDA NIH HHS UG1 DA049444
6 · The paper itself

Abstract

Background: There exist substantial patient barriers to accessing medications for opioid use disorder (MOUD), including travel distance, stigma, and availability of MOUD providers. Yet, despite these barriers, there exists a subset of patients who possess the requisite motivation to seek and remain adherent to treatment. Objective: To explore patient-derived goals in MOUD treatment-adherent patients. Methods: This study used in-depth interviews with patients receiving methadone who were enrolled in opioid treatment programs (OTPs) across Tennessee. Participants were recruited from 12 different OTPs to participate in telephonic semi-structured interviews to a point of saturation. Participants had to be adherent to treatment, in treatment for 6 months or greater, and English speaking. Analysis occurred inductively using a constructivist approach to Grounded Theory. Results: In total, 17 patient interviews were conducted in the spring of 2021. Participants described goal setting across three general stages of treatment: (1) addressing acute physical and emotional needs upon treatment entry, (2) development of supportive structure and routine to develop healthy skills facilitated by treatment team, and (3) identifying and pursuing future-focused goals not directly linked to treatment. A Proximal Goals in MOUD Framework is introduced. Conclusion: In this qualitative study on patient reported goals in MOUD it was found that goals are transitory and relative to the stage of treatment. Further research is needed to better understand goal evolution over the course of treatment and its impact on treatment retention.

Indexed as

Medication for opioid use disorderOpioid use disorderPatient-centered carePatient reported outcomes

Identifiers

PMID37876851
PMCPMC10590992
OpenAlexW4387358556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.